66 related articles for article (PubMed ID: 31773688)
1. Correlation between gene polymorphism and opioid efficacy in patients with gastric or intestinal cancer.
Pu J; Wang N; Huang ZK; He XY; Yuan HB
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(21):9393-9410. PubMed ID: 31773688
[TBL] [Abstract][Full Text] [Related]
2. Effect of
Chen Y; Chen Q; Cai C; Lin X; Yu W; Huang H; Xie W; Lin M; Chen W; Wu H; Su T; Wang L
Pharmacogenomics; 2023 Aug; 24(12):675-684. PubMed ID: 37610885
[No Abstract] [Full Text] [Related]
3. Comparison of the Effects of OPRM1 A118G Polymorphism Using Different Opioids: A Prospective Study.
Takemura M; Niki K; Okamoto Y; Kawamura T; Kohno M; Matsuda Y; Ikeda K
J Pain Symptom Manage; 2024 Jan; 67(1):39-49.e5. PubMed ID: 37757956
[TBL] [Abstract][Full Text] [Related]
4. Study on the association between adverse drug reactions to opioids and gene polymorphisms: a case-case-control study.
Yang J; Sun YZ; Li QF; Fu Z; Guan YY; Song C; Zheng L
BMC Pharmacol Toxicol; 2023 Nov; 24(1):64. PubMed ID: 37990344
[TBL] [Abstract][Full Text] [Related]
5. The influence of COMT and ABCB1 gene polymorphisms on sufentanil analgesic effect for postoperative pain in children with fracture.
Wang H; An J; Zhong S; Qiao S; Zhang L; Zhao L; Wang C
Medicine (Baltimore); 2024 Apr; 103(17):e37980. PubMed ID: 38669362
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms in the A118G SNP of the OPRM1 gene produce different experiences of opioids: A human laboratory phenotype-genotype assessment.
Dunn KE; Huhn AS; Finan PH; Mange A; Bergeria CL; Maher BS; Rabinowitz JA; Strain EC; Antoine D
Addict Biol; 2024 Jan; 29(1):e13355. PubMed ID: 38221808
[TBL] [Abstract][Full Text] [Related]
7. Impact of OPRM1 (Mu-opioid Receptor Gene) A112G Polymorphism on Dual Oxycodone and Cocaine Self-administration Behavior in a Mouse Model.
Zhang Y; Randesi M; Blendy JA; Kreek MJ; Butelman ER
Neuroscience; 2024 Feb; 539():76-85. PubMed ID: 38211933
[TBL] [Abstract][Full Text] [Related]
8. μ-Opioid receptor gene (OPRM1) polymorphism in patients with breast cancer.
Cieślińska A; Sienkiewicz-Szłapka E; Kostyra E; Fiedorowicz E; Snarska J; Wroński K; Tenderenda M; Jarmołowska B; Matysiewicz M
Tumour Biol; 2015 Jun; 36(6):4655-60. PubMed ID: 25618602
[TBL] [Abstract][Full Text] [Related]
9. Dose selection of central or peripheral administration of sufentanil affect opioid induced cough?: a prospective, randomized, controlled trial.
He J; Zhu L; Zhu H; Gu X; Li P; Yang Y; Yang L
BMC Anesthesiol; 2018 Apr; 18(1):38. PubMed ID: 29636004
[TBL] [Abstract][Full Text] [Related]
10. Neural Network Connectivity Following Opioid Dependence is Altered by a Common Genetic Variant in the µ-Opioid Receptor,
Xie Y; Brynildsen JK; Windisch K; Blendy JA
J Neurosci; 2024 Feb; 44(6):. PubMed ID: 38124015
[TBL] [Abstract][Full Text] [Related]
11. Mu-Opioid Receptor 1 and C-Reactive Protein Single Nucleotide Polymorphisms as Biomarkers of Pain Intensity and Opioid Consumption.
Turczynowicz A; Jakubów P; Niedźwiecka K; Kondracka J; Pużyńska W; Tałałaj M; Guszczyn T; Grabala P; Kowalczuk O; Kocańda S
Brain Sci; 2023 Nov; 13(12):. PubMed ID: 38137077
[TBL] [Abstract][Full Text] [Related]
12. Effects of oxycodone pharmacogenetics on postoperative analgesia and related clinical outcomes in children: a pilot prospective study.
Aruldhas BW; Quinney SK; Packiasabapathy S; Overholser BR; Raymond O; Sivam S; Sivam I; Velu S; Montelibano A; Sadhasivam S
Pharmacogenomics; 2023 Mar; 24(4):187-197. PubMed ID: 36946298
[No Abstract] [Full Text] [Related]
13. Implication of OPRM1 A118G Polymorphism in Opioids Addicts in Pakistan: In vitro and In silico Analysis.
Ahmed M; Ul Haq I; Faisal M; Waseem D; Taqi MM
J Mol Neurosci; 2018 Aug; 65(4):472-479. PubMed ID: 30033503
[TBL] [Abstract][Full Text] [Related]
14. Importance of cytochrome 3A4 and 2D6-mediated drug-drug interactions in oxycodone consumption among older adults hospitalized for hip fracture: a cross-sectional study.
Decaix T; Gautier S; Royer L; Laprévote O; Tritz T; Siguret V; Teillet L; Sellier C; Pépin M
Aging Clin Exp Res; 2023 Nov; 35(11):2471-2481. PubMed ID: 37861957
[TBL] [Abstract][Full Text] [Related]
15. The effects of OPRM1 118A>G on methadone response in pain management in advanced cancer at end of life.
Haupt LM; Haywood A; Sutherland HG; Yu C; Albury CL; Pharasi A; Zunk M; George R; Griffiths LR; Good P; Hardy J
Sci Rep; 2024 Feb; 14(1):3411. PubMed ID: 38341456
[TBL] [Abstract][Full Text] [Related]
16. Contribution of CYP2D6 Functional Activity to Oxycodone Efficacy in Pain Management: Genetic Polymorphisms, Phenoconversion, and Tissue-Selective Metabolism.
Deodhar M; Turgeon J; Michaud V
Pharmaceutics; 2021 Sep; 13(9):. PubMed ID: 34575542
[TBL] [Abstract][Full Text] [Related]
17. OPRM1 Gene Polymorphism in Women with Alcohol Use Disorder.
Boroń A; Suchanecka A; Chmielowiec K; Śmiarowska M; Chmielowiec J; Strońska-Pluta A; Recław R; Grzywacz A
Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474311
[TBL] [Abstract][Full Text] [Related]
18. Retracted: Comparison of a Small Dose of Oxycodone and Sufentanil for the Prevention of Sufentanil-Induced Cough during General Anesthesia Induction: A Prospective Randomized Controlled Trial.
Methods In Medicine CAM
Comput Math Methods Med; 2023; 2023():9798531. PubMed ID: 37475911
[TBL] [Abstract][Full Text] [Related]
19. Drug Positivity Findings from a Universal Umbilical Cord Tissue Drug Analysis Program in Appalachia.
Yossuck P; Tacker DH
J Appl Lab Med; 2021 Jan; 6(1):285-297. PubMed ID: 33324976
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
